微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 9.24% | -0.35% | -13.01% | 126/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 10.62% | -1.43% | 5.3% | 127/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 10.08% | -2.58% | -0.72% | 127/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 10.16% | -1.39% | 9.59% | 128/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 9.27% | -11.87% | -13.96% | 126/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 10.77% | -8.3% | 4.07% | 127/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 10.35% | -14.1% | 0.49% | 124/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 10.3% | -15.87% | -2.06% | 128/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 10.52% | -12.42% | -10.47% | 123/139 | 53.36% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 11.75% | -11.12% | -2.51% | 127/139 | 53.18% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 12.05% | 2% | -1.58% | 121/139 | 54.03% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 12.24% | -6.81% | 1.95% | 122/139 | 53.47% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 12.01% | 2% | -9.14% | 118/139 | 53.71% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 13.22% | -6.52% | 0.6% | 125/139 | 53.71% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 13.14% | 29.74% | -7.08% | 123/139 | 54.84% | 三友医疗 | 90.14% | 行业排名> |
| 2021-12-31 | 14.14% | -6.81% | 39.63% | 125/139 | 57.28% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 10.13% | -7.02% | -33.26% | 117/139 | 58.4% | 三友医疗 | 90.73% | 行业排名> |
| 2020-12-31 | 15.17% | 3.7% | 39.32% | 125/139 | 59.49% | 三友医疗 | 90.5% | 行业排名> |
| 2020-06-30 | 10.89% | 2% | -25.57% | 110/139 | 59.82% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 14.63% | 2% | 2% | 118/139 | 56.29% | 正海生物 | 90.78% | 行业排名> |